全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Elektra J. Papadopoulos , Elizabeth Nicole Bush , Sonya Eremenco ...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.151-153
摘要:Abstract(#br)Assessment of clinical benefit in treatment trials can be made through report by a clinician, a patient, or a nonclinician observer (eg, caregiver) or through a performance-based assessment. The US Food and Drug Administration (FDA) published a final guidance fo...
作者:Daniel Gladwell , Ash Bullement , Warren Cowell ...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.191-199
摘要:Abstract(#br)Background(#br)Changes in the regulatory context enable faster approval of transformative medicines. They also lead to health technology assessment (HTA) agencies having to make decisions with less evidence. In response, HTA agencies have also initiated forms of...
作者:Diego Tlapa , Carlos A. Zepeda-Lugo , Guilherme L. Tortorella ...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.260-273
摘要:Abstract(#br)Objectives(#br)To assess the effects of lean healthcare (LH) on patient flow in ambulatory care and determine whether waiting time and length of stay (LOS) decrease after LH interventions.(#br)Methods(#br)A systematic review was performed with close adherence to Pref...
作者:Bram Roudijk , A. Rogier T. Donders , Peep F.M. Stalmeier
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.236-241
摘要:Abstract(#br)Objectives(#br)The valuation of health states worse than dead is challenging. Currently used time trade-off methods face problems in (1) detecting time-dependent preferences and (2) insensitivity toward severity for states worse than dead. The better-than-dead (...
作者:Khachen Kongpakwattana , Nathorn Chaiyakunapruk
来源:[J].Value in Health(IF 2.191), 2020
摘要:Abstract(#br)Objectives(#br)Decision-analytic models for Alzheimer’s disease (AD) have been advanced to a discrete-event simulation (DES), in which individual-level modeling of disease progression across continuous severity spectra become feasible. This study aimed to apply ...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.vi-vi
作者:Elisabeth Fenwick , Lotte Steuten , Saskia Knies ...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.139-150
摘要:Abstract(#br)Healthcare resource allocation decisions made under conditions of uncertainty may turn out to be suboptimal. In a resource constrained system in which there is a fixed budget, these suboptimal decisions will result in health loss. Consequently, there may be value in ...
作者:Joseph T. Kannarkat , Chester B. Good , Natasha Parekh
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.154-156
摘要:Abstract(#br)Value-based pharmaceutical contracts (VBPCs) are performance-based reimbursement agreements between healthcare payers and pharmaceutical manufacturers in which the price, amount, or nature of reimbursement is tied to value-based outcomes. VBPCs are often complex...
来源:[J].Value in Health(IF 2.191), 2020, Vol.23 (2), pp.i-iv

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×